{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:40:46Z","timestamp":1791247246364,"version":"4.1.0"},"reference-count":113,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Early-onset colorectal cancer (EOCRC), defined as diagnosis before the age of 50 years, is increasing globally and is frequently characterized by aggressive biology and a disproportionate burden of liver metastases. This review synthesizes emerging evidence on the distinct molecular, immunologic and clinical features that differentiate EOCRC liver metastases from those arising in older adults. Genomic studies revealed increased chromosomal instability, increased copy number variation burden and unique amplification patterns involving MYC, RAD21, GNAS and MAPK1, alongside altered frequencies of classical driver mutations and increased germline predisposition. EOCRC liver metastases also exhibit a progenitor-like transcriptional state and an immune-cold microenvironment marked by reduced myeloid infiltration, impaired antigen presentation and profound resistance to immunotherapy, particularly in microsatellite-stable disease. Mechanistic insights into ferroptosis highlight therapeutic vulnerabilities, especially in PIK3CA-mutant tumors, where aspirin and ferroptosis inducers show synergistic potential. Clinically, high-risk EOCRC patients often present with left-sided primary tumors, synchronous metastases, adverse histology, elevated CEA levels and a hereditary predisposition, with prognostic models incorporating these variables outperforming traditional staging. Collectively, accumulating evidence suggests that EOCRC liver metastases may represent a biologically and clinically distinct entity, although ongoing debates regarding the extent of this distinction underscore the need for age-specific molecular profiling and prospectively validated therapeutic strategies.<\/jats:p>","DOI":"10.3390\/ijms27073289","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T02:06:21Z","timestamp":1775441181000},"page":"3289","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Molecular Signature of Early-Onset Colorectal Cancer Liver Metastases: Distinct Biology and Clinical Challenges"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1703-6980","authenticated-orcid":false,"given":"Sophia","family":"Tsokkou","sequence":"first","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1632-821X","authenticated-orcid":false,"given":"Ioannis","family":"Konstantinidis","sequence":"additional","affiliation":[{"name":"Laboratory of Histology-Embryology, Department of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Chatzikomnitsa","sequence":"additional","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-7009","authenticated-orcid":false,"given":"Menelaos","family":"Papakonstantinou","sequence":"additional","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1245-7804","authenticated-orcid":false,"given":"Areti Danai","family":"Gkaitatzi","sequence":"additional","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokia","family":"Toutziari","sequence":"additional","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2654-5845","authenticated-orcid":false,"given":"Dimitrios","family":"Alexandrou","sequence":"additional","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6023-4744","authenticated-orcid":false,"given":"Dimitrios","family":"Giakoustidis","sequence":"additional","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1009-1685","authenticated-orcid":false,"given":"Vasileios N.","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-4609","authenticated-orcid":false,"given":"Alexandros","family":"Giakoustidis","sequence":"additional","affiliation":[{"name":"First Department of Surgery, General Hospital Papageorgiou, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.2147\/CMAR.S554044","article-title":"The Rise of Early-Onset Colorectal Cancer: Clinical Characteristics and Outcomes in a Young Patient Population","volume":"17","author":"Tashkandi","year":"2025","journal-title":"Cancer Manag. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMra2200869","article-title":"Increasing Incidence of Early-Onset Colorectal Cancer","volume":"386","author":"Sinicrope","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.annonc.2025.07.019","article-title":"Incidence Trends and Long-Term Survival in Early-Onset Colorectal Cancer: A Nationwide Swedish Study","volume":"36","author":"Barot","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/jama.2025.10218","article-title":"Early-Onset Gastrointestinal Cancers","volume":"334","author":"Jayakrishnan","year":"2025","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/S1470-2045(21)00588-X","article-title":"A Comprehensive Framework for Early-Onset Colorectal Cancer Research","volume":"23","author":"Eng","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1470-2045(25)00239-6","article-title":"Patterns in Genomic Mutations among Patients with Early-Onset Colorectal Cancer: An International, Multicohort, Observational Study","volume":"26","author":"Li","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41416-024-02902-5","article-title":"Early Onset Metastatic Colorectal Cancer Patients as a Distinctive Clinical and Molecular Phenomenon","volume":"132","author":"Pretta","year":"2025","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10732748251363337","DOI":"10.1177\/10732748251363337","article-title":"Differential Analysis of Early-Onset and Late-Onset Colorectal Cancer Based on Multidimensional Evidence Integration: A Review","volume":"32","author":"Mi","year":"2025","journal-title":"Cancer Control"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kibriya, M.G., Raza, M., Quinn, A., Kamal, M., Ahsan, H., and Jasmine, F. (2022). A Transcriptome and Methylome Study Comparing Tissues of Early and Late Onset Colorectal Carcinoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214261"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lawler, T., Parlato, L., and Warren Andersen, S. (2024). The Histological and Molecular Characteristics of Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1349572"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/JS9.0000000000003463","article-title":"Clinicopathological Characteristics and Biomarker Alterations in Early-Onset vs. Late-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis","volume":"112","author":"Huang","year":"2025","journal-title":"Int. J. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","article-title":"The Rising Tide of Early-Onset Colorectal Cancer: A Comprehensive Review of Epidemiology, Clinical Features, Biology, Risk Factors, Prevention, and Early Detection","volume":"7","author":"Patel","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ailawadi, S., Kaelber, D.C., and Elangovan, A. (2025). Early-Onset Colorectal Cancer: A Review of Current Insights and a Call for Action. Biomedicines, 13.","DOI":"10.3390\/biomedicines13071572"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41698-025-01129-8","article-title":"Single-Cell Integration Analysis Reveals Molecular Signatures of the Tumor Microenvironment in Early-Onset Colorectal Cancer","volume":"9","author":"Peng","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s12276-021-00583-1","article-title":"High Prevalence of TP53 Loss and Whole-Genome Doubling in Early-Onset Colorectal Cancer","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mc.22315","article-title":"DNA Copy Number Profiling Reveals Different Patterns of Chromosomal Instability within Colorectal Cancer According to the Age of Onset","volume":"55","author":"Arriba","year":"2016","journal-title":"Mol. Carcinog."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105756","DOI":"10.1016\/j.esmoop.2025.105756","article-title":"Early-Onset Colorectal Cancer Patients Exhibit a Distinct Molecular Fingerprint: Insights from a Large-Scale NGS Study of 1209 Patients","volume":"10","author":"Pretta","year":"2025","journal-title":"ESMO Open"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1097\/JS9.0000000000001584","article-title":"Molecular Characteristics of Early-Onset Compared with Late-Onset Colorectal Cancer: A Case Controlled Study","volume":"110","author":"Tang","year":"2024","journal-title":"Int. J. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/cncr.31994","article-title":"Clinical and Molecular Characterization of Early-onset Colorectal Cancer","volume":"125","author":"Willauer","year":"2019","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.21037\/jgo-21-205","article-title":"Co-Amplification of Genes in Chromosome 8q24: A Robust Prognostic Marker in Hepatocellular Carcinoma","volume":"12","author":"Zheng","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oncolo\/oyae011","article-title":"Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers","volume":"29","author":"Ngoi","year":"2024","journal-title":"Oncologist"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nguyen, N.T., Sennoune, S.R., Dharmalingam-Nandagopal, G., Sivaprakasam, S., Bhutia, Y.D., and Ganapathy, V. (2024). Impact of Oncogenic Changes in P53 and KRAS on Macropinocytosis and Ferroptosis in Colon Cancer Cells and Anticancer Efficacy of Niclosamide with Differential Effects on These Two Processes. Cells, 13.","DOI":"10.20944\/preprints202404.0092.v1"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"109897","DOI":"10.1016\/j.surg.2025.109897","article-title":"Clinicopathologic Characteristics, Genomic Signatures, and Outcomes of Patients Undergoing Resection for Early- versus Late-Onset Colorectal Liver Metastasis","volume":"191","author":"Tsilimigras","year":"2025","journal-title":"Surgery"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/jso.26797","article-title":"Association of Genomic Profiles and Survival in Early Onset and Screening-age Colorectal Cancer Patients with Liver Metastases Resected over 15 Years","volume":"125","author":"Narayan","year":"2022","journal-title":"J. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Li, G.M., Xiao, G.Z., Qin, P.F., Wan, X.Y., Fu, Y.J., Zheng, Y.H., Luo, M.Y., Ren, D.L., Liu, S.P., and Chen, H.X. (2022). Single-Cell RNA Sequencing Reveals Heterogeneity in the Tumor Microenvironment between Young-Onset and Old-Onset Colorectal Cancer. Biomolecules, 12.","DOI":"10.3390\/biom12121860"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e15711","DOI":"10.1200\/JCO.2025.43.16_suppl.e15711","article-title":"Evaluating the Immune Landscape in Early Onset Colorectal Cancer Patients","volume":"43","author":"Vadehra","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1200\/JCO.2025.43.16_suppl.3545","article-title":"Tumour Microbiome and Immune Dysregulation in Early-Onset Colorectal Cancer","volume":"43","author":"Purcell","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Men\u00e9ndez, C., Rodr\u00edguez-P\u00e9rez, J., Fuertes, D., Leguizamon, V., Gonz\u00e1lez-Sanmart\u00edn, M., Mateos, E., Cervero, M., San Jos\u00e9, E., Sanz, G., and \u00c1lvaro, E. (2025). Differences in the Peripheral Blood Immune Landscape between Early-Onset and Late-Onset Colorectal Cancer. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1692382"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/jnci\/djae143","article-title":"Differences in Tumor-Associated T-Cell Receptor Repertoires between Early-Onset and Average-Onset Colorectal Cancer","volume":"116","author":"Tsai","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Andric, F., Al-Fairouzi, A., Wettergren, Y., Szeponik, L., Bexe-Lindskog, E., Cusack, J.C., Tumusiime, G., Quiding-J\u00e4rbrink, M., and Ljungman, D. (2023). Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer. Cancers, 15.","DOI":"10.3390\/cancers15051457"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1200\/JCO.2021.39.15_suppl.3519","article-title":"Microbiome Signature, Global Methylation and Immune Landscape in Early Onset Colorectal Cancer","volume":"39","author":"Jin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1200\/JCO.2024.42.16_suppl.3580","article-title":"Microbiome Signature, Immune Landscape and Global Methylation in Early Onset Colorectal Cancer","volume":"42","author":"Jin","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling Pathways Involved in Colorectal Cancer: Pathogenesis and Targeted Therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100974","DOI":"10.1016\/j.xcrm.2023.100974","article-title":"Integrated Multi-Omics Approach to Distinct Molecular Characterization and Classification of Early-Onset Colorectal Cancer","volume":"4","author":"Du","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver Metastasis Restrains Immunotherapy Efficacy via Macrophage-Mediated T Cell Elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e2346094","DOI":"10.1001\/jamanetworkopen.2023.46094","article-title":"Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients with Refractory Metastatic Colorectal Cancer","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e2118416","DOI":"10.1001\/jamanetworkopen.2021.18416","article-title":"Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1\/Programmed Cell Death Ligand 1 in Patients with Treatment-Resistant Microsatellite Stable Colorectal Cancer with and Without Liver Metastases","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2023.41.16_suppl.3552","article-title":"Alternating Short-Course Oxaliplatin-Based Chemotherapy and Nivolumab as First-Line Treatment of Patients with Abdominal Metastases from Microsatellite-Stable (MSS) Colorectal Cancer (CRC): A Randomized Phase 2 Trial","volume":"41","author":"Ree","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1200\/JCO.2025.43.16_suppl.3533","article-title":"Metastatic Site Pattern as Predictor of Outcome of First-Line Alternating Oxaliplatin-Based Chemotherapy and Nivolumab for Patients with Microsatellite-Stable (MSS) Colorectal Cancer (CRC)","volume":"43","author":"Ree","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wu, Q., Wang, Z., Luo, Y., and Xie, X. (2023). Efficacy and Safety of Immune Checkpoint Inhibitors in Proficient Mismatch Repair (PMMR)\/Non-Microsatellite Instability-High (Non-MSI-H) Metastatic Colorectal Cancer: A Study Based on 39 Cohorts Incorporating 1723 Patients. BMC Immunol., 24.","DOI":"10.1186\/s12865-023-00564-1"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"218061","DOI":"10.1016\/j.canlet.2025.218061","article-title":"An Anti-PD-1 Antibody (SCT-I10A) plus Anti-EGFR Antibody (SCT200) and Chemotherapy for RAS\/BRAF Wild-Type Metastatic Colorectal Cancer: A Phase Ib Study","volume":"634","author":"Bai","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/1078-0432.CCR-21-1193","article-title":"The Liver\u2013Immunity Nexus and Cancer Immunotherapy","volume":"28","author":"Lee","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ros, J., Balconi, F., Baraibar, I., Saoudi Gonzalez, N., Salva, F., Tabernero, J., and Elez, E. (2023). Advances in Immune Checkpoint Inhibitor Combination Strategies for Microsatellite Stable Colorectal Cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1112276"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"104775","DOI":"10.1016\/j.critrevonc.2025.104775","article-title":"Immunotherapy in Microsatellite-Stable Colorectal Cancer: Strategies to Overcome Resistance","volume":"212","author":"Chen","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/s41467-025-56748-3","article-title":"Regorafenib plus Sintilimab as a Salvage Treatment for Microsatellite Stable Metastatic Colorectal Cancer: A Single-Arm, Open-Label, Phase II Clinical Trial","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102460","DOI":"10.1016\/j.ctrv.2022.102460","article-title":"Regorafenib in Combination with Immune Checkpoint Inhibitors for Mismatch Repair Proficient (PMMR)\/Microsatellite Stable (MSS) Colorectal Cancer","volume":"110","author":"Bregni","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2353\/ajpath.2007.061099","article-title":"CD8+ T Cells Promote Inflammation and Apoptosis in the Liver after Sepsis","volume":"171","author":"Chung","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2105323118","DOI":"10.1073\/pnas.2105323118","article-title":"Dendritic Cell Paucity in Mismatch Repair\u2013Proficient Colorectal Cancer Liver Metastases Limits Immune Checkpoint Blockade Efficacy","volume":"118","author":"Ho","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","article-title":"IL-10 Dampens Antitumor Immunity and Promotes Liver Metastasis via PD-L1 Induction","volume":"80","author":"Shiri","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41588-025-02380-2","article-title":"TGF-\u03b2 Builds a Dual Immune Barrier in Colorectal Cancer by Impairing T Cell Recruitment and Instructing Immunosuppressive SPP1+ Macrophages","volume":"57","author":"Henriques","year":"2025","journal-title":"Nat. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1158\/0008-5472.CAN-25-0079","article-title":"Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer","volume":"86","author":"Fumet","year":"2026","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12967-025-06351-3","article-title":"Single-Cell Transcriptomic Analysis Reveals Dynamic Changes in the Liver Microenvironment during Colorectal Cancer Metastatic Progression","volume":"23","author":"Jiang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e70024","DOI":"10.1002\/biof.70024","article-title":"Targeting Cellular Energetics via Ferroptosis Mediated Cell Death in Resistant Colorectal Cancer Stem Cells","volume":"51","author":"Biswas","year":"2025","journal-title":"BioFactors"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Hu, B., Yin, Y., Li, S., and Guo, X. (2022). Insights on Ferroptosis and Colorectal Cancer: Progress and Updates. Molecules, 28.","DOI":"10.3390\/molecules28010243"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"113524","DOI":"10.1016\/j.biopha.2022.113524","article-title":"Ferroptosis in Colorectal Cancer: Potential Mechanisms and Effective Therapeutic Targets","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.3748\/wjg.v29.i16.2433","article-title":"Ferroptosis Regulates Key Signaling Pathways in Gastrointestinal Tumors: Underlying Mechanisms and Therapeutic Strategies","volume":"29","author":"Rabitha","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"16479","DOI":"10.1007\/s00210-025-04324-3","article-title":"NRF2 as a Ferroptosis Gatekeeper in Colorectal Cancer: Implications for Therapy","volume":"398","author":"Alkhathami","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"39542","DOI":"10.1038\/s41598-025-23180-y","article-title":"NCOA4-Mediated Ferroptosis Conducive to EMT Inhibition in Colorectal Cancer Cells Was Achieved through the PI3K\/AKT\/MTOR Pathway","volume":"15","author":"Fu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ponvilawan, B., Sakornsakolpat, P., Pongpaibul, A., Roothumnong, E., Akewanlop, C., Pithukpakorn, M., and Korphaisarn, K. (2025). Comprehensive Genomic Analysis in Sporadic Early-Onset Colorectal Adenocarcinoma Patients. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-13745-5"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10147-021-02101-9","article-title":"Clinicopathological and Molecular Characteristics of Early-Onset vs Late-Onset Colorectal Cancer According to Tumor Location","volume":"27","author":"Chen","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1200\/JCO.2023.41.16_suppl.3511","article-title":"Evaluation of Genomic Alterations in Early-Onset versus Late-Onset Colorectal Cancer","volume":"41","author":"Lander","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.humpath.2020.08.002","article-title":"Unique Clinicopathologic and Genetic Alteration Features in Early Onset Colorectal Carcinoma Compared with Age-Related Colorectal Carcinoma: A Large Cohort next Generation Sequence Analysis","volume":"105","author":"Escobar","year":"2020","journal-title":"Hum. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2504650","article-title":"Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer","volume":"393","author":"Martling","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1158\/1078-0432.CCR-24-4048","article-title":"Adjuvant Aspirin Treatment in PIK3CA -Mutated Colon Cancer Patients: The SAKK 41\/13 Prospective Randomized Placebo-Controlled Double-Blind Trial","volume":"31","author":"Hayoz","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-022-04430-y","article-title":"Aspirin Sensitivity of PIK3CA-Mutated Colorectal Cancer: Potential Mechanisms Revisited","volume":"79","author":"Hall","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic Activation of PI3K-AKT-MTOR Signaling Suppresses Ferroptosis via SREBP-Mediated Lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Xia, W., Lv, Y., Zou, Y., Kang, Z., Li, Z., Tian, J., Zhou, H., Su, W., and Zhong, J. (2025). The Role of Ferroptosis in Colorectal Cancer and Its Potential Synergy with Immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1526749"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, Y., and Cheng, X. (2024). Enhancing Colorectal Cancer Immunotherapy: The Pivotal Role of Ferroptosis in Modulating the Tumor Microenvironment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179141"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T Cells Regulate Tumour Ferroptosis during Cancer Immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1111\/febs.16034","article-title":"Emerging Roles of Ferroptosis in the Tumor Immune Landscape: From Danger Signals to Anti-tumor Immunity","volume":"289","author":"Shi","year":"2022","journal-title":"FEBS J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00018-025-05982-5","article-title":"Ferroptosis and Cancer: When Iron Turns against Tumors","volume":"83","author":"Toyokuni","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"122386","DOI":"10.1016\/j.biomaterials.2023.122386","article-title":"Biomimetic Inducer Enabled Dual Ferroptosis of Tumor and M2-Type Macrophages for Enhanced Tumor Immunotherapy","volume":"303","author":"Chen","year":"2023","journal-title":"Biomaterials"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"104907","DOI":"10.1016\/j.critrevonc.2025.104907","article-title":"Ferroptosis and Immunotherapy: Breaking Barriers in Cancer Treatment Resistance","volume":"214","author":"Ebrahimnezhad","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1158\/0008-5472.CAN-21-1547","article-title":"A Dual PI3K\/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy","volume":"81","author":"Fan","year":"2021","journal-title":"Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"103796","DOI":"10.1016\/j.redox.2025.103796","article-title":"Ferroptosis Triggers Anti-Tumor Immunity via Promoting Chaperone-Mediated Autophagic Degradation of SHP2","volume":"86","author":"Zhu","year":"2025","journal-title":"Redox Biol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Zhang, T., Gu, F., Lin, W., Shao, H., Jiang, A., and Guan, X. (2025). Boosting Cancer Immunotherapy: Drug Delivery Systems Leveraging Ferroptosis and Immune Checkpoint Blockade. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1611299"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.34934","article-title":"The Engineered Exosomes Targeting Ferroptosis: A Novel Approach to Reverse Immune Checkpoint Inhibitors Resistance","volume":"155","author":"Chen","year":"2024","journal-title":"Int. J. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Cai, Y., Zhao, F., and Cheng, X. (2025). Gut Microbiota and Ferroptosis in Colorectal Cancer: A Comprehensive Review of Mechanisms and Therapeutic Strategies to Overcome Immune Checkpoint Resistance. Biomolecules, 15.","DOI":"10.3390\/biom15111546"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.1038\/s41467-024-54706-z","article-title":"Tumor-Derived MiR-9-5p-Loaded EVs Regulate Cholesterol Homeostasis to Promote Breast Cancer Liver Metastasis in Mice","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1136\/gutjnl-2025-334851","article-title":"Extracellular Vesicle-Induced Lipid Dysregulation Drives Liver Premetastatic Niche Formation in Colorectal Cancer","volume":"74","author":"Cao","year":"2025","journal-title":"Gut"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.7150\/thno.55609","article-title":"Organ-Specific Cholesterol Metabolic Aberration Fuels Liver Metastasis of Colorectal Cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/procel\/pwaf092","article-title":"Lipid Deposition Promotes YTHDF3-Mediated M6A Modification of PPAR\u03b1 to Facilitate Liver Metastasis of Colorectal Cancer","volume":"17","author":"Ni","year":"2026","journal-title":"Protein Cell"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Martino, E., Balestrieri, A., Aragona, F., Bifulco, G., Mele, L., Campanile, G., Balestrieri, M.L., and D\u2019Onofrio, N. (2023). MiR-148a-3p Promotes Colorectal Cancer Cell Ferroptosis by Targeting SLC7A11. Cancers, 15.","DOI":"10.3390\/cancers15174342"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/mc.23367","article-title":"MiR-15a-3p Regulates Ferroptosis via Targeting Glutathione Peroxidase GPX4 in Colorectal Cancer","volume":"61","author":"Liu","year":"2022","journal-title":"Mol. Carcinog."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"154557","DOI":"10.1016\/j.prp.2023.154557","article-title":"MiR-509-5p Promotes Colorectal Cancer Cell Ferroptosis by Targeting SLC7A11","volume":"247","author":"Elrebehy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jamasurg.2021.2380","article-title":"Characteristics of Early-Onset vs Late-Onset Colorectal Cancer","volume":"156","author":"Zaborowski","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"32828","DOI":"10.1038\/s41598-025-18118-3","article-title":"A Nomogram and Random Forest Model for Predicting Liver Metastasis in Patients with Early-Onset Colorectal Cancer","volume":"15","author":"Han","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"37698","DOI":"10.1038\/s41598-025-21410-x","article-title":"Prognostic Model for Early-Onset Colorectal Cancer with Liver Metastasis after Primary Tumor Resection and Chemotherapy","volume":"15","author":"Tang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","article-title":"Marital Status and Survival in Patients with Cancer","volume":"31","author":"Aizer","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.18632\/oncotarget.3129","article-title":"The Influence of Marital Status on Stage at Diagnosis and Survival of Patients with Colorectal Cancer","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00384-018-3017-7","article-title":"The Effect of Marital Status by Age on Patients with Colorectal Cancer over the Past Decades: A SEER-Based Analysis","volume":"33","author":"Feng","year":"2018","journal-title":"Int. J. Color. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Gasser, E., Braunwarth, E., Riedmann, M., Cardini, B., Fadinger, N., Presl, J., Klieser, E., Ellmerer, P., Dupr\u00e9, A., and Imai, K. (2019). Primary Tumour Location Affects Survival after Resection of Colorectal Liver Metastases: A Two-Institutional Cohort Study with International Validation, Systematic Meta-Analysis and a Clinical Risk Score. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217411"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/bjs.11289","article-title":"Meta-Analysis of the Association between Primary Tumour Location and Prognosis after Surgical Resection of Colorectal Liver Metastases","volume":"106","author":"Wang","year":"2019","journal-title":"Br. J. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/SLA.0000000000003504","article-title":"The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status","volume":"273","author":"Margonis","year":"2021","journal-title":"Ann. Surg."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/1078-0432.CCR-23-3275","article-title":"Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG\/AGITG CO.17 and CO.20 Randomized Clinical Trials","volume":"30","author":"Chen","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2022.01.012","article-title":"Predicting 10-Year Survival after Resection of Colorectal Liver Metastases; an International Study Including Biomarkers and Perioperative Treatment","volume":"168","author":"Buisman","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00384-022-04175-x","article-title":"Nomogram Predicting the Cancer-Specific Survival of Early-Onset Colorectal Cancer Patients with Synchronous Liver Metastasis: A Population-Based Study","volume":"37","author":"Ding","year":"2022","journal-title":"Int. J. Color. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/SLA.0000000000002664","article-title":"Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases","volume":"269","author":"Margonis","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/CEJ.0000000000000859","article-title":"Meta-Analysis of the Prognostic Value of Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer Liver Metastases after Hepatectomy","volume":"33","author":"Yuan","year":"2024","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1245\/s10434-022-12301-w","article-title":"Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases","volume":"29","author":"Yoshino","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1245\/s10434-022-11973-8","article-title":"Impact of Preoperative CEA Uptrend on Survival Outcomes in Patients with Colorectal Liver Metastasis After Hepatectomy","volume":"29","author":"Hori","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.hpb.2016.09.004","article-title":"Pre-Hepatectomy Carcinoembryonic Antigen (CEA) Levels among Patients Undergoing Resection of Colorectal Liver Metastases: Do CEA Levels Still Have Prognostic Implications?","volume":"18","author":"Sasaki","year":"2016","journal-title":"HPB"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/SLA.0b013e318190eddc","article-title":"Prognosis of Patients with Colorectal Cancer Is Associated with Lymph Node Ratio","volume":"248","author":"Rosenberg","year":"2008","journal-title":"Ann. Surg."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/bjc.2015.211","article-title":"Prognostic Value of Lymph Node Ratio and Extramural Vascular Invasion on Survival for Patients Undergoing Curative Colon Cancer Resection","volume":"113","author":"Parnaby","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Cao, Y., Ke, S., Deng, S., Yan, L., Gu, J., Mao, F., Xue, Y., Zheng, C., Cai, W., and Liu, H. (2021). Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients with Liver Metastasis: A Population-Based Study. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.719638"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e2529093","DOI":"10.1001\/jamanetworkopen.2025.29093","article-title":"Dynamic Prognostic Models for Colorectal Cancer with Liver Metastases","volume":"8","author":"Chen","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1038\/s41467-022-34890-6","article-title":"MTOR Inhibition Attenuates Chemosensitivity through the Induction of Chemotherapy Resistant Persisters","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/15384101.2022.2123187","article-title":"Mechanistic Target of Rapamycin (MTOR) Regulates Self-Sustained Quiescence, Tumor Indolence, and Late Clinical Metastasis in a Beclin-1-Dependent Manner","volume":"22","author":"Nicco","year":"2023","journal-title":"Cell Cycle"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.3748\/wjg.v30.i33.3810","article-title":"Colorectal Cancer Cell Dormancy: An Insight into Pathways","volume":"30","author":"Kumar","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"104822","DOI":"10.1016\/j.critrevonc.2025.104822","article-title":"Regulatory Mechanisms and Therapeutic Targeting of Metastatic Tumor Dormancy in Colorectal Cancer: A Comprehensive Review","volume":"213","author":"Chen","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/ijc.33047","article-title":"Cotargeting BET Proteins Overcomes Resistance Arising from PI3K\/MTOR Blockade-Induced Protumorigenic Senescence in Colorectal Cancer","volume":"147","author":"Lee","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-022-05426-1","article-title":"Colon Tumour Cell Death Causes MTOR Dependence by Paracrine P2X4 Stimulation","volume":"612","author":"Schmitt","year":"2022","journal-title":"Nature"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1245\/s10434-013-3146-8","article-title":"Significance of MTOR Signaling and Its Inhibitor against Cancer Stem-like Cells in Colorectal Cancer","volume":"21","author":"Cai","year":"2014","journal-title":"Ann. Surg. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3289\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T02:15:09Z","timestamp":1775441709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":113,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27073289"],"URL":"https:\/\/doi.org\/10.3390\/ijms27073289","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]}}}